INTERNATIONAL PATENT: KITE PHARMA, INC. FILES APPLICATION FOR "FACTORS FOR OPTIMIZING IMMUNOTHERAPY EFFICACY"

GENEVA, May 14 -- KITE PHARMA, INC. (2400 BroadwaySanta Monica, California 90404) filed a patent application (PCT/US2024/053531) for "FACTORS FOR OPTIMIZING IMMUNOTHERAPY EFFICACY" on Oct 30, 2024. With publication no. WO/2025/096517, the details related to the patent application was published on May 08, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MATTIE, Michael D. (Kite Pharma, Inc.c/o Gilead Sciences, Inc.333 Lakeside DriveFoster City, California 94404)

Abstract: The disclosure relates to methods for predicting a likelihood of a relapse to a cancer in a patient, methods for predict...